LT3250182T - Dispersinės kompozicijos - Google Patents

Dispersinės kompozicijos

Info

Publication number: LT3250182T
Authority: LT; Lithuania
Prior art keywords: dispersive compositions; dispersive; compositions
Prior art date: 2015-01-27

Application number

LTEPPCT/EP2016/051545T

Other languages

English (en)

Inventor

Manish Gupta

Shripad Marathe

Kaustubh TAMBWEKAR

Shreedevi Nair

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-01-27

Filing date

2016-01-26

Publication date

2023-07-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55229712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3250182(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-01-26 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2023-07-10 Publication of LT3250182T publication Critical patent/LT3250182T/lt

Links

239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Lubricants (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LTEPPCT/EP2016/051545T 2015-01-27 2016-01-26 Dispersinės kompozicijos LT3250182T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN264MU2015		2015-01-27
PCT/EP2016/051545 WO2016120258A1 (en)	2015-01-27	2016-01-26	Dispersible compositions

Publications (1)

Publication Number	Publication Date
LT3250182T true LT3250182T (lt)	2023-07-10

Family

ID=55229712

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEPPCT/EP2016/051545T LT3250182T (lt)	2015-01-27	2016-01-26	Dispersinės kompozicijos

Country Status (29)

Country	Link
US (2)	US20180000810A1 (lt)
EP (1)	EP3250182B1 (lt)
JP (3)	JP7291458B2 (lt)
KR (1)	KR102631986B1 (lt)
CN (2)	CN114129526A (lt)
AU (2)	AU2016212116B2 (lt)
CY (1)	CY1126107T1 (lt)
DK (1)	DK3250182T3 (lt)
EA (1)	EA201791701A1 (lt)
ES (1)	ES2948805T3 (lt)
FI (1)	FI3250182T3 (lt)
HK (1)	HK1243644A1 (lt)
HR (1)	HRP20230616T1 (lt)
HU (1)	HUE062481T2 (lt)
IL (2)	IL310920A (lt)
LT (1)	LT3250182T (lt)
MA (1)	MA41411B1 (lt)
MD (1)	MD3250182T2 (lt)
MX (1)	MX391192B (lt)
PE (1)	PE20171319A1 (lt)
PH (1)	PH12017501331B1 (lt)
PL (1)	PL3250182T3 (lt)
PT (1)	PT3250182T (lt)
RS (1)	RS64308B1 (lt)
SG (1)	SG11201705944TA (lt)
SI (1)	SI3250182T1 (lt)
SM (1)	SMT202300188T1 (lt)
UA (1)	UA126891C2 (lt)
WO (1)	WO2016120258A1 (lt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2937365C (en)	2016-03-29	2018-09-18	F. Hoffmann-La Roche Ag	Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2019012100A1 (en) *	2017-07-14	2019-01-17	Janssen Pharmaceutica Nv	EXTENDED ACTION FORMULATIONS
WO2019193609A1 (en) *	2018-04-05	2019-10-10	Cipla Limited	Pharmaceutical formulations
US11291654B2 (en) *	2018-09-13	2022-04-05	Syneurx International (Taiwan) Corp.	Formulations of cycloserine compounds and applications thereof
WO2020123336A1 (en) *	2018-12-13	2020-06-18	Qrumpharma Inc.	Compositions of bedaquiline, combinations comprising them, processes for their preparation, uses and methods of treatment comprising them
KR20210113628A (ko) *	2019-01-09	2021-09-16	얀센 파마슈티카 엔.브이.	비결핵성 마이코박테리아 질환의 치료에서의 조합물
WO2021257466A1 (en) *	2020-06-15	2021-12-23	The Global Alliance For Tb Drug Development, Inc.	Combination antibacterial composition and method for antibacterial therapy
WO2021257461A1 (en) *	2020-06-15	2021-12-23	Mylan Laboratories Limited	Combination antibacterial composition and method for antibacterial therapy
CN111888477B (zh) *	2020-09-15	2023-03-07	北京福元医药股份有限公司	一种贝达喹啉药物制剂
KR20230107275A (ko) *	2020-11-12	2023-07-14	얀센 파마슈티카 엔.브이.	비결핵성 마이코박테리아 질환의 치료에서 베다퀼린, 에탐부톨 및 마크롤라이드의 조합물
KR102478006B1 (ko)	2020-12-03	2022-12-15	정승찬	자동차 긴급 제동장치
GB202100470D0 (en) *	2021-01-14	2021-03-03	Summit Oxford Ltd	Solid tablet dosage for of ridinilazole
US11793808B2 (en)	2021-02-22	2023-10-24	Mannkind Corp.	Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
GB202211231D0 (en)	2022-08-02	2022-09-14	Glaxosmithkline Ip No 2 Ltd	Novel formulation
CN120731072A (zh) *	2022-12-17	2025-09-30	维亚治疗有限责任公司	用于治疗儿科结核病的氯法齐明迷你片剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1527050E (pt)	2002-07-25	2010-06-22	Janssen Pharmaceutica Nv	Derivados de quinolina e sua utilização como inibidores de micobactérias
JO2524B1 (en) *	2004-05-28	2010-03-17	جانسن فارمسيتكا ان في	Use of substituted quinoline derivatives to treat drug-resistant microbial diseases
EE05394B1 (et)	2004-12-24	2011-04-15	Janssen Pharmaceutica N.V.	Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
EP1888604B1 (en) *	2005-05-25	2012-03-14	Janssen Pharmaceutica NV	Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
EE05697B1 (et) *	2005-06-08	2014-02-17	Janssen Pharmaceutica N.V.	Kinoliini derivaadid kui antibakteriaalsed toimeained
WO2008017867A2 (en) *	2006-08-10	2008-02-14	Cipla Limited	Antiretroviral solid oral composition with at least one water insoluble polymer
UA97813C2 (uk) *	2006-12-05	2012-03-26	Янссен Фармацевтика Н.В.	Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
JO3271B1 (ar) *	2006-12-06	2018-09-16	Janssen Pharmaceutica Nv	مشتقات الكوينولين المضادة للجراثيم
WO2009146097A1 (en) *	2008-04-02	2009-12-03	Dr. Reddy's Laboratories Ltd.	Raloxifene pharmaceutical formulations
MX2011002348A (es) *	2008-09-03	2011-06-27	Pfizer	Terapia de combinacion para tuberculosis.
US20120207838A1 (en) *	2011-02-10	2012-08-16	Perricone Nicholas V	Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps
WO2013153162A1 (en) *	2012-04-11	2013-10-17	Sandoz Ag	Polymorph of rilpivirine hydrochloride
US20140075692A1 (en) *	2012-09-18	2014-03-20	Unger Marketing International, Llc.	Multiuse cleaning tool handle
WO2014075692A1 (en) *	2012-11-19	2014-05-22	Azanta A/S	Dispersible tablet

2016
- 2016-01-26 CN CN202111218462.7A patent/CN114129526A/zh active Pending
- 2016-01-26 PH PH1/2017/501331A patent/PH12017501331B1/en unknown
- 2016-01-26 UA UAA201708632A patent/UA126891C2/uk unknown
- 2016-01-26 KR KR1020177023308A patent/KR102631986B1/ko active Active
- 2016-01-26 US US15/545,524 patent/US20180000810A1/en not_active Abandoned
- 2016-01-26 JP JP2017557493A patent/JP7291458B2/ja active Active
- 2016-01-26 MD MDE20170303T patent/MD3250182T2/ro unknown
- 2016-01-26 IL IL310920A patent/IL310920A/en unknown
- 2016-01-26 PL PL16701516.3T patent/PL3250182T3/pl unknown
- 2016-01-26 SI SI201631721T patent/SI3250182T1/sl unknown
- 2016-01-26 SM SM20230188T patent/SMT202300188T1/it unknown
- 2016-01-26 WO PCT/EP2016/051545 patent/WO2016120258A1/en not_active Ceased
- 2016-01-26 DK DK16701516.3T patent/DK3250182T3/da active
- 2016-01-26 LT LTEPPCT/EP2016/051545T patent/LT3250182T/lt unknown
- 2016-01-26 EP EP16701516.3A patent/EP3250182B1/en active Active
- 2016-01-26 AU AU2016212116A patent/AU2016212116B2/en active Active
- 2016-01-26 HK HK18103261.6A patent/HK1243644A1/zh unknown
- 2016-01-26 MX MX2017009681A patent/MX391192B/es unknown
- 2016-01-26 CN CN201680007314.1A patent/CN107205945A/zh active Pending
- 2016-01-26 PE PE2017001255A patent/PE20171319A1/es unknown
- 2016-01-26 IL IL253626A patent/IL253626B2/en unknown
- 2016-01-26 HU HUE16701516A patent/HUE062481T2/hu unknown
- 2016-01-26 RS RS20230495A patent/RS64308B1/sr unknown
- 2016-01-26 MA MA41411A patent/MA41411B1/fr unknown
- 2016-01-26 EA EA201791701A patent/EA201791701A1/ru unknown
- 2016-01-26 FI FIEP16701516.3T patent/FI3250182T3/fi active
- 2016-01-26 SG SG11201705944TA patent/SG11201705944TA/en unknown
- 2016-01-26 PT PT167015163T patent/PT3250182T/pt unknown
- 2016-01-26 HR HRP20230616TT patent/HRP20230616T1/hr unknown
- 2016-01-26 ES ES16701516T patent/ES2948805T3/es active Active
2021
- 2021-02-12 JP JP2021020595A patent/JP2021098706A/ja active Pending
- 2021-06-21 AU AU2021204135A patent/AU2021204135B2/en active Active
2022
- 2022-02-03 US US17/592,097 patent/US20220331307A1/en not_active Abandoned
- 2022-08-22 JP JP2022131578A patent/JP2022176982A/ja not_active Withdrawn
2023
- 2023-07-07 CY CY20231100319T patent/CY1126107T1/el unknown

Also Published As

Publication number	Publication date
AU2021204135A1 (en)	2021-07-15
HRP20230616T1 (hr)	2023-09-29
DK3250182T3 (da)	2023-06-26
PT3250182T (pt)	2023-07-07
AU2016212116B2 (en)	2021-07-15
KR20170106447A (ko)	2017-09-20
IL253626B2 (en)	2024-08-01
MX391192B (es)	2025-03-21
MA41411A (fr)	2017-12-05
HUE062481T2 (hu)	2023-11-28
PL3250182T3 (pl)	2023-07-31
EA201791701A1 (ru)	2017-11-30
SI3250182T1 (sl)	2023-08-31
PH12017501331B1 (en)	2024-02-14
CY1126107T1 (el)	2023-11-15
MX2017009681A (es)	2017-10-18
BR112017015784A2 (pt)	2018-03-27
US20180000810A1 (en)	2018-01-04
SMT202300188T1 (it)	2023-07-20
HK1243644A1 (zh)	2018-07-20
JP2018502928A (ja)	2018-02-01
JP2022176982A (ja)	2022-11-30
AU2021204135B2 (en)	2023-10-05
JP7291458B2 (ja)	2023-06-15
EP3250182B1 (en)	2023-04-26
ES2948805T3 (es)	2023-09-19
EP3250182A1 (en)	2017-12-06
IL253626B1 (en)	2024-04-01
IL310920A (en)	2024-04-01
AU2016212116A1 (en)	2017-07-27
PE20171319A1 (es)	2017-09-07
MA41411B1 (fr)	2023-07-31
US20220331307A1 (en)	2022-10-20
WO2016120258A1 (en)	2016-08-04
CA2973301A1 (en)	2016-08-04
MD3250182T2 (ro)	2023-09-30
IL253626A0 (en)	2017-09-28
JP2021098706A (ja)	2021-07-01
RS64308B1 (sr)	2023-07-31
CN114129526A (zh)	2022-03-04
FI3250182T3 (fi)	2023-06-28
CN107205945A (zh)	2017-09-26
UA126891C2 (uk)	2023-02-22
KR102631986B1 (ko)	2024-01-30
PH12017501331A1 (en)	2017-12-11
SG11201705944TA (en)	2017-08-30

Publication	Publication Date	Title
EP3534968A4 (en)	2020-07-01	ANTI-BCMA T CAR LYMPHOCYTE COMPOSITIONS
DK3361870T3 (da)	2020-05-11	Fungicidsammensætninger
EP3334403A4 (en)	2019-03-20	TOPICAL COMPOSITIONS
DK3307288T3 (da)	2019-10-07	Sammensætninger omfattende bakteriestammer
DK3204025T3 (da)	2019-11-25	Sammensætninger omfattende bakteriestammer
DK3206700T3 (da)	2019-08-05	Sammensætninger omfattende bakteriestammer
DK3204024T3 (da)	2019-10-07	Sammensætninger omfattende bakteriestammer
HUE049233T2 (hu)	2020-09-28	C9ORF72-expresszió módosítására szolgáló készítmények
EP3339331A4 (en)	2019-05-01	COMPOSITION
EP3398996A4 (en)	2019-07-31	COMPOSITION
DK3542812T3 (da)	2021-04-12	Glycopeptidsammensætninger
DK3250182T3 (da)	2023-06-26	Dispergible sammensætninger
DK3334726T3 (da)	2022-05-16	Plinabulinsammensætninger
MA42692A (fr)	2018-07-04	Compositions biopharmaceutiques
EP3397239A4 (en)	2019-08-28	TOPICAL COMPOSITIONS
PT3261437T (pt)	2019-11-29	Compostos e composições fungicidas
MA45090A (fr)	2021-04-28	Compositions anticancéreuses
EP3336527A4 (en)	2019-04-17	X-ray fluorescence spectrometer
EP3395887C0 (en)	2024-08-28	FLUOROR RUBBER COMPOSITION
DK3322295T3 (da)	2022-12-19	Sammensætning
DK4234656T3 (da)	2026-04-20	Sammensætninger
DK3397352T3 (da)	2021-08-23	Antiperspirantsammensætninger
DK3316857T3 (da)	2021-10-18	Multifasiske sammensætninger
DK3317458T3 (da)	2024-05-21	Mineralsammensætninger
LT3528791T (lt)	2024-05-27	Dispersinės kompozicijos